AAVrh10-PCCA Gene Therapy for Propionic Acidemia
AAVrh10-PCCA Gene Therapy for Propionic Acidemia (NCT07643844)
OrganizationBiotech
Mayo Clinic
Organization linked by public source evidence.
Public IDs
No public external ID is attached.
Related people
No reviewed person affiliation is attached.
Outputs
No reviewed output is linked through affiliated people.
Topics
Relationship evidence
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer (NCT03179904)
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas (NCT07468136)
Timeline
No dated relationship evidence is attached.